IGC Pharma, Inc. Annual Return On Assets in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
IGC Pharma, Inc. quarterly/annual Return On Assets history and growth rate from 2012 to 2023.
  • IGC Pharma, Inc. Return On Assets for the quarter ending September 30, 2024 was -119 %, a 91.7% decline year-over-year.
  • IGC Pharma, Inc. annual Return On Assets for 2023 was -62.4 %, a 71.3% decline from 2022.
  • IGC Pharma, Inc. annual Return On Assets for 2022 was -36.4 %, a 30.5% increase from 2021.
  • IGC Pharma, Inc. annual Return On Assets for 2021 was -52.4 %, a 88% decline from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -62.4 -26 -71.3% Apr 1, 2023 Mar 31, 2024
2022 -36.4 +16 +30.5% Apr 1, 2022 Mar 31, 2023
2021 -52.4 -24.5 -88% Apr 1, 2021 Mar 31, 2022
2020 -27.9 +1.49 +5.08% Apr 1, 2020 Mar 31, 2021
2019 -29.4 +10 +25.5% Apr 1, 2019 Mar 31, 2020
2018 -39.4 -27.4 -230% Apr 1, 2018 Mar 31, 2019
2017 -11.9 -2.2 -22.6% Apr 1, 2017 Mar 31, 2018
2016 -9.74 +3.57 +26.8% Apr 1, 2016 Mar 31, 2017
2015 -13.3 +12 +47.3% Apr 1, 2015 Mar 31, 2016
2014 -25.3 -11.8 -87.6% Apr 1, 2014 Mar 31, 2015
2013 -13.5 -3.88 -40.5% Apr 1, 2013 Mar 31, 2014
2012 -9.59 Apr 1, 2012 Mar 31, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.